-+ 0.00%
-+ 0.00%
-+ 0.00%

SMITH+NEPHEW CEO: EXPECT MEDICARE REIMBURSEMENT PROPOSALS ON SKIN SUBSTITUTES TO BE HEADWIND TO WOUND UNIT SALES & PROFITABILITY IN 2026 - CONF CALL

Reuters·08/05/2025 07:43:25

Please log in to view news